U.S. Pharma Stock News

Main Street Capital (MAIN) has wrapped up FY 2025 with fourth quarter revenue of US$145.5 million and basic EPS of US$1.46. This sets the tone for a year in which trailing twelve month revenue reached US$566.4 million and EPS was US$5.52. Over recent periods, the company has reported quarterly revenue ranging between US$137.0 million and US$145.5 million, while basic EPS has moved between US$1.31 and US$1.46. Trailing net income for the year was US$493.4 million, as investors weigh those...

In the first quarter ended March 31, 2026, Revolve Group, Inc. reported sales of US$342.88 million, net income of US$14.35 million, and diluted earnings per share from continuing operations of US$0.20, all higher than a year earlier. This past-quarter improvement in both revenue and profitability gives investors fresh data to reassess how Revolve’s growth investments may be translating into earnings power. With first-quarter revenue and net income both higher year over year, we’ll now...

D-Market Elektronik Hizmetler ve Ticaret A.S. recently released its first-quarter 2026 results, reporting sales of TRY 23,136.56 million compared with TRY 18,827.87 million a year earlier, alongside a net loss of TRY 991.97 million versus TRY 464.69 million previously. The combination of strong top-line expansion and a larger loss underlines how D-Market’s growth investments and cost structure are still weighing on profitability. Next, we’ll examine how this strong revenue growth but wider...

Gran Tierra Energy (NYSEAM:GTE) has wrapped up FY 2025 with fourth quarter revenue of US$132.6 million and a basic EPS loss of US$3.99, alongside a full year trailing revenue base of US$596.7 million and a trailing basic EPS loss of US$5.45. Over recent periods, the company has seen quarterly revenue range from US$147.0 million to US$170.5 million. Basic EPS has moved between a small profit of US$0.04 in late 2024 and losses including US$0.54 in the first quarter of 2025, setting up an...

Wondering if Matador Resources at around US$55.57 is offering solid value or asking too much for its growth story? This article walks through the key signals to help you judge whether the current price looks appealing. The stock has pulled back with a 12.4% decline over the last 7 days and a 13.8% decline over the last 30 days, even though the year to date return sits at 28.2% and the 1 year return at 35.3%. Recent coverage has focused on Matador Resources in the context of broader energy...

NI Holdings (NODK) just closed out FY 2025 with Q4 total revenue of US$61.0 million and a basic EPS loss of US$0.15, alongside a net loss of US$3.2 million, putting margins firmly under pressure. Over recent quarters, total revenue has moved from US$73.9 million in Q4 2024 to US$71.4 million in Q1 2025 and US$76.1 million in Q2 2025 before landing at US$61.0 million in Q4 2025, while EPS has swung from a profit of US$0.47 in Q4 2024 to a loss of US$0.57 in Q2 2025 and a loss of US$0.15 in the...

Sharplink (NasdaqCM:SBET) has wrapped up FY 2025 with Q4 revenue of US$15.8 million and basic EPS of a US$3.51 loss, against a backdrop of trailing twelve month revenue of US$28.1 million and basic EPS of a US$7.37 loss. Over recent quarters, the company has seen quarterly revenue move from US$0.7 million in Q1 2025 to US$10.8 million in Q3 2025 and then US$15.8 million in Q4 2025, while EPS shifted from a US$1.73 loss in Q1 to EPS of US$0.70 in Q3 and back to a US$3.51 loss in Q4. This puts...

Investors may be wondering whether Huron Consulting Group at around US$124.78 is starting to look attractive, or if the stock price still reflects too much optimism. The share price has slipped by about 4.5% over the past week and 5.2% over the past month, adding to a 27.1% decline year to date and an 18.0% return over the last year. This contrasts with the 3-year and 5-year returns, which stand at 54.7% and 126.4% respectively. These recent moves sit against a backdrop of ongoing interest...

Investors may be wondering if Capricor Therapeutics at around US$33.94 is still offering value after a strong run, or if most of the opportunity is already reflected in the price. The stock has returned 1.1% over the last week, 6.2% over the past month and 19.9% year to date, with a very large 1 year return of 386.9% and around 7x over 3 years. This naturally raises questions about the current balance of risk and reward. Recent coverage has focused on Capricor Therapeutics because of its...

Wondering if USA Rare Earth at around US$26.38 is still offering value after a strong run, or if you are late to the party? This breakdown focuses squarely on what the current price might be implying. The stock has recent returns of 1.6% over 7 days, 80.2% over 30 days, 86.4% year to date and 163.8% over the past year, which will naturally raise questions about how much optimism is already priced in. Recent coverage of USA Rare Earth has highlighted growing investor attention on rare earth...

If you are wondering whether Flutter Entertainment's current share price really reflects what you are getting for your money, this article breaks down how the stock looks on several valuation yardsticks. After closing at US$101.20, the stock has seen a 6.2% decline over the past week, a 2.3% decline over the last month, and a 53.6% decline year to date. It has also declined 58.0% over the last year and 49.0% and 43.1% over the past 3 and 5 years respectively. Recent coverage has focused on...

Esperion Therapeutics (ESPR) closed out FY 2025 with fourth quarter revenue of US$168.4 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$403.1 million and a basic EPS loss of US$0.11. Over recent quarters the company has seen revenue move from US$69.1 million in Q4 2024 to US$168.4 million in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 in Q4 2024 to EPS of US$0.26 in Q4 2025. This sets up a results season in which investors will be weighing how...

If you are wondering whether Gilat Satellite Networks at around US$18.84 is priced for opportunity or disappointment, the starting point is to understand what the current valuation is really implying. The stock has posted returns of 2.1% over the last 7 days and 2.2% over the last 30 days, with year to date returns of 40.5% and a 1 year return of 189.0%, alongside a 3 year return of 243.2% and a 5 year return of 119.8%. Recent news flow around Gilat Satellite Networks has focused on its...

Wondering if Aptiv's current share price reflects its true worth, or if the recent swings are masking a clearer story about value. Aptiv closed at US$57.11, with returns of a 5.2% decline over 7 days, a 1.9% decline over 30 days, a 27.2% decline year to date, but a 10.3% gain over the past year, which can leave the stock looking quite different depending on the time frame you focus on. Those mixed returns sit against a backdrop of ongoing attention on Aptiv as an auto components supplier, as...

Geospace Technologies (GEOS) opened Q1 2026 with revenue of US$25.6 million and a basic EPS loss of US$0.76, alongside a trailing twelve month basic EPS loss of US$2.17 on revenue of US$99.2 million. Over recent quarters the company has reported revenue between US$18.0 million and US$37.2 million, while EPS has ranged from a profit of US$0.66 per share in Q1 2025 to several loss-making quarters since. For investors, that mix of fluctuating topline and persistent losses keeps the attention on...

Janus Henderson Group (JHG) closed out FY 2025 with fourth quarter revenue of US$1.1 billion and basic EPS of US$2.64, capping a trailing twelve month net income of US$798.3 million on basic EPS of US$5.25. Over the past year, total revenue has moved from US$2.5 billion on trailing basic EPS of US$2.57 to US$3.1 billion on trailing basic EPS of US$5.25, alongside an improvement in net profit margin from 16.1% to 25.8%. This puts earnings quality front and center for investors assessing the...

If you are wondering whether Par Pacific Holdings at US$62.25 is still attractively priced after a strong run, the next sections will walk through what the current market price may be implying about the stock. The share price has pulled back with a 5.2% decline over the last week and a 3.7% decline over the last month, even though the year to date return stands at 73.8% and the 1 year return at 255.1%. Recent news coverage has focused on Par Pacific Holdings as an oil and gas refiner and...

Assertio Holdings (ASRT) closed out FY 2025 with Q4 revenue of US$13.5 million and basic EPS of a US$1.86 loss, alongside a trailing twelve month revenue base of US$118.7 million and basic EPS of a US$4.74 loss. Over the past year, quarterly revenue has moved between US$26.5 million and US$49.5 million, while quarterly basic EPS has ranged from a US$2.56 loss to US$1.78, leaving investors focused on how these shifts are feeding through to underlying margins. See our full analysis for Assertio...

SIFCO Industries (SIF) opened Q1 2026 with total revenue of US$24.0 million and net income of US$1.8 million, translating to basic EPS of US$0.29 for the quarter. The company has seen quarterly revenue move from US$21.7 million in Q4 2024 to US$20.9 million in Q1 2025 and then to US$24.0 million in Q1 2026. Basic EPS shifted from a loss of US$0.25 in Q4 2024 and US$0.40 in Q1 2025 to a profit of US$0.29 in the latest period. This sets up an earnings season in which investors are likely to...

Enerpac Tool Group Corp. recently expanded its leadership team, promoting Phil Jefferson to Executive Vice President and Chief Commercial Officer with added oversight of the Asia Pacific region, and elevating Mart Hinnen to Executive Vice President of Innovation & Heavy Industrial Technologies with responsibility for the Heavy Lifting Technology and DTA businesses. The promotions consolidate global commercial and innovation leadership under two experienced insiders, potentially sharpening...

Token Cat (TC) has just posted its H1 2025 numbers, with revenue of C¥19.8 million and a net income loss of C¥0.7 million, translating to basic EPS of C¥5.74 loss per share, while trailing 12 month figures show revenue of C¥36.6 million and a net loss of C¥148.0 million, or C¥1,200.49 loss per share. Over recent half year periods the company has seen revenue move from C¥32.3 million in H1 2024 to C¥16.9 million in H2 2024 and then to C¥19.8 million in H1 2025. Over the same periods, EPS...

Afya (NasdaqGS:AFYA) reports revenue and EBITDA growth, highlighting resilient financial performance in its latest earnings update. The Medical Practice Solutions segment faces pressure from declining active payers and stronger competition from AI driven tools. These developments point to a mixed picture for Afya, with solid headline results and emerging challenges beneath the surface. Afya operates across medical education and healthcare services in Brazil, and its latest report underlines...

For readers considering whether Sprouts Farmers Market at around US$80.99 still represents good value, or whether the key part of the move has already occurred, this article outlines what the current price may be implying. The stock has been choppy recently, with a 1% slip over the last week, a 5% gain over the last month, a modest 0.4% return year to date, and a 48.8% decline over the past year. This sits alongside a 120.3% return over three years and 212.8% over five years. These moves...

If you are wondering whether Arrowhead Pharmaceuticals at around US$77.95 is still offering value or has already run too far, this breakdown is designed to help you frame that question clearly. The stock has returned 6.1% over the past week, 27.4% over the last 30 days, 15.0% year to date, and 488.3% over the past year, which naturally raises questions about how much of the story is already priced in. Recent coverage has focused on Arrowhead Pharmaceuticals' progress in RNA interference...